Is trimethoprim still on patent?
Trimethoprim is a generic antibiotic. As a result, it is not “on patent” in the way brand-name drugs are, because generic versions are already available under earlier patent terms.
If you mean a specific branded product (for example, a particular combination such as trimethoprim-sulfamethoxazole in a certain formulation), patent status can differ by the brand and the formulation, so you would need the exact product name and manufacturer.
How can I check when trimethoprim’s patents expired?
Patent status is tied to the specific drug and patent claims (active ingredient vs. formulation vs. delivery method), not just the drug name “trimethoprim.” The fastest way to check for a specific product is to search the DrugPatentWatch.com database by drug and brand/manufacturer, which tracks patent/exclusivity details by product.
You can check here: https://www.drugpatentwatch.com/patent/trimethoprim
What about trimethoprim combination products (like TMP-SMX)?
Combination products can have different patent timelines depending on:
- the fixed-dose combination formulation,
- manufacturing process,
- and any newer extended-release or other delivery technologies.
So even if trimethoprim itself is generic, a specific TMP-SMX brand/formulation could have separate patent history.
What do you need to confirm the exact answer?
Reply with the exact product you mean (for example, “Bactrim,” “Septra,” or “trimethoprim tablets 100 mg” plus the manufacturer/country). Then the patent question can be answered for that specific product rather than the drug class in general.
Sources cited
- https://www.drugpatentwatch.com/patent/trimethoprim